12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Regencell Bioscience RGC shares rose 175.07% to $17.33 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 277.4K shares, making up 587.65% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $219.1 million.
  • Geovax Labs GOVX stock rose 53.95% to $6.62. The current volume of 76.0 million shares is 9643.03% of Geovax Labs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $41.8 million.
  • XTL Biopharmaceuticals XTLB shares rose 16.59% to $4.63. As of 12:30 EST, this security is trading at a volume of 1.2 million shares, making up 1217.01% of its average full-day volume over the last 100 days. The company's market cap stands at $24.4 million.
  • Organovo Holdings ONVO shares rose 15.29% to $7.01. The current volume of 180.1K shares is 78.59% of Organovo Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $61.0 million.
  • Accelerate Diagnostics AXDX stock increased by 13.73% to $6.21. As of 12:30 EST, this security is trading at a volume of 172.4K shares, making up 107.93% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $381.9 million.
  • Allogene Therapeutics ALLO stock moved upwards by 13.25% to $23.8. Trading volume for this security as of 12:30 EST is 849.6K, which is 69.54% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 billion.

 

 

Losers

 

  • Progenity PROG shares decreased by 55.45% to $0.66 during Friday's regular session. The current volume of 32.6 million shares is 1332.46% of Progenity's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $52.7 million.
  • Sonnet BioTherapeutics SONN stock declined by 50.28% to $0.61. The current volume of 38.9 million shares is 935.01% of Sonnet BioTherapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $12.9 million. The company's, Q3 earnings came out 4 days ago.
  • Endo International ENDP shares declined by 36.06% to $2.27. As of 12:30 EST, this security is trading at a volume of 23.9 million shares, making up 419.45% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $530.0 million.
  • Sonoma Pharmaceuticals SNOA stock declined by 24.05% to $6.19. Sonoma Pharmaceuticals's stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 172.67% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million. As per the news, the Q1 earnings report came out 4 days ago.
  • Fate Therapeutics FATE stock fell 19.39% to $69.03. As of 12:30 EST, this security is trading at a volume of 3.6 million shares, making up 406.06% of its average full-day volume over the last 100 days. The company's market cap stands at $6.5 billion.
  • Ensysce Biosciences ENSC stock decreased by 18.02% to $3.14. Trading volume for Ensysce Biosciences's stock is 1.0 million as of 12:30 EST. This is 47.6% of its average full-day volume over the last 100 days. The company's market cap stands at $76.1 million.

 

 

Market News and Data brought to you by Benzinga APIs
Posted In: Intraday UpdateMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...